Behaviour and assessment of bioavailability of organic contaminants in soil: relevance for risk assessment and remediation

Abstract. Soils contaminated with organic chemicals are now widespread in industrialized and developing countries, and the risk assessment and remediation of such contaminated sites is a priority. However, containment and remediation strategies are complicated in many cases by the range of contaminants present and the historical nature of the contamination. Research has increased our understanding of the behaviour of organic contaminants in soil and the factors that control their behaviour. There is a fundamental need to understand and, where possible, quantify the bioavailable fraction as well as the total concentration of contaminant present in soil: the bioavailable fraction is key to toxicity or biodegradation. To quantify these fractions, a large number of techniques have been employed, ranging from organic and aqueous based solvent extractions to the use of biota. Many studies have been carried out investigating the use of chemical techniques to describe bioavailability, which could be used in the assessment and remediation of contaminated land. The aim of this review is to consider the behaviour of organic contaminants in soil, highlighting issues of bioavailability, and then to discuss the relevance of the various methods for assessing risk and potential remediation of organic contaminants in soil.     

Untangling desmosomal knots with electron tomography

Cell adhesion by adherens junctions and desmosomes relies on interactions between cadherin molecules. However, the molecular interfaces that define molecular specificity and that mediate adhesion remain controversial. We used electron tomography of plastic sections from neonatal mouse skin to visualize the organization of desmosomes in situ. The resulting three-dimensional maps reveal individual cadherin molecules forming discrete groups and interacting through their tips. Fitting of an x-ray crystal structure for C-cadherin to these maps is consistent with a flexible intermolecular interface mediated by an exchange of amino-terminal tryptophans. This flexibility suggests a novel mechanism for generating both cis and trans interactions and for propagating these adhesive interactions along the junction.     

Cyclooxygenase Expression and Platelet Function in Healthy Dogs Receiving Low‐Dose Aspirin

Background

Low‐dose aspirin is used to prevent thromboembolic complications in dogs, but some animals are nonresponsive to the antiplatelet effects of aspirin (“aspirin resistance”).

Hypothesis/Objectives

That low‐dose aspirin would inhibit platelet function, decrease thromboxane synthesis, and alter platelet cyclooxygenase (COX) expression.

Animals

Twenty‐four healthy dogs.

Methods

A repeated measures study. Platelet function (PFA‐100 closure time, collagen/epinephrine), platelet COX‐1 and COX‐2 expression, and urine 11‐dehydro‐thromboxane B₂ (11‐dTXB₂) were evaluated before and during aspirin administration (1 mg/kg Q24 hours PO, 10 days). Based on prolongation of closure times after aspirin administration, dogs were divided into categories according to aspirin responsiveness: responders, nonresponders, and inconsistent responders.

Results

Low‐dose aspirin increased closure times significantly (62% by Day 10, P < .001), with an equal distribution among aspirin responsiveness categories, 8 dogs per group. Platelet COX‐1 mean fluorescent intensity (MFI) increased significantly during treatment, 13% on Day 3 (range, ?29.7–136.1%) (P = .047) and 72% on Day 10 (range, ?0.37–210%) (P < .001). Platelet COX‐2 MFI increased significantly by 34% (range, ?29.2–270%) on Day 3 (P = .003) and 74% (range, ?19.7–226%) on Day 10 (P < .001). Urinary 11‐dTXB₂ concentrations significantly (P = .005, P < .001) decreased at both time points. There was no difference between aspirin responsiveness and either platelet COX expression or thromboxane production.

Conclusions and Clinical Importance

Low‐dose aspirin consistently inhibits platelet function in approximately one‐third of healthy dogs, despite decreased thromboxane synthesis and increased platelet COX expression in most dogs. COX isoform expression before treatment did not predict aspirin resistance.

     

Managing Sources and Sinks of Greenhouse Gases in Australia’s Rangelands and Tropical Savannas

Rangelands and savannas occupy 70% of the Australian continent and are mainly used for commercial grazing of sheep and cattle. In the center and north, where there are extensive areas of indigenous land ownership and pastoral production is less intensive, savanna burning is frequent. Greenhouse gas emissions from rangelands have been overwhelmingly from land clearing and methane production by livestock. Reductions in the rate of land clearing have substantially reduced Australia’s greenhouse gas emissions, but these have been controversial with the reduced potential pasture production being of concern to many land managers. Reductions in direct livestock emissions are possible through manipulation of the genetics, rumen flora, or diet of animals. However, the greatest potential benefit is a whole-property approach with improved animal husbandry and attention to other aspects of property management such as fossil fuel consumption. Focus on emissions per unit of land area is likely to have other ecological benefits for land condition and to capture the effects of changes in carbon stocks in vegetation and soils. In much of northern and central Australia, changes in settlement patterns have led to more frequent and intense fires than under indigenous management regimes before European settlement. The implementation of more benign regimes of savanna burning has great potential benefit for greenhouse abatement, biodiversity, and livelihoods of indigenous people in remote settlements.